Sign in
Abstract 5388: Targeting, biodistribution, and in vivo effects of MV-muPA, a novel oncolytic measles virus fully retargeted against uPAR in syngeneic, immunocompetent cancer models
Journal article   Peer reviewed

Abstract 5388: Targeting, biodistribution, and in vivo effects of MV-muPA, a novel oncolytic measles virus fully retargeted against uPAR in syngeneic, immunocompetent cancer models

Yuqi Jing, Julia Zaias, Krisztina Kovacs and Jaime Merchan
Cancer research (Chicago, Ill.), Vol.71(8 Supplement), pp.5388-5388
2011-04-15

Metrics

8 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details